Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Revenue (2018 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) posted Revenue of $149.39 million for Q1 2026, up 5.6% from $141.42 million a year earlier but down 2.1% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Revenue (2018 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Revenue at Catalyst Pharmaceuticals was $596.96 million, up 11.7% year-over-year; for FY2025, it was $588.99 million, up 19.8% from FY2024.

  • Annual Revenue has increased for six consecutive years, with a five-year compound annual growth rate of 37.7% (FY2020 to FY2025).
  • In prior years, Catalyst Pharmaceuticals' Revenue was $491.73 million in FY2024 (+23.5%), $398.2 million in FY2023 (+85.9%), $214.2 million in FY2022 (+52.1%) and $140.83 million in FY2021 (+18.3%).
  • Quarterly Revenue has run from a low of $35.95 million in Q3 2021 to a high of $152.61 million in Q4 2025 over five years.
  • On a year-over-year basis, Revenue has increased in each of the last 22 quarters, with growth averaging 21.0% over the last eight quarters.
  • Across the past five years, year-over-year growth in Revenue ran from 5.6% in Q1 2026 to 98.1% in Q1 2023.
  • According to Business Quant data, Revenue for the three prior quarters was $152.61 million (Q4 2025), $148.39 million (Q3 2025) and $146.56 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 149.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 149.39 Mn
Dec 31, 2025 152.61 Mn
Sep 30, 2025 148.39 Mn
Jun 30, 2025 146.56 Mn
Mar 31, 2025 141.42 Mn
Dec 31, 2024 141.82 Mn
Sep 30, 2024 128.70 Mn
Jun 30, 2024 122.71 Mn
Mar 31, 2024 98.51 Mn
Dec 31, 2023 110.57 Mn
Sep 30, 2023 102.69 Mn
Jun 30, 2023 99.58 Mn
Mar 31, 2023 85.37 Mn
Dec 31, 2022 60.76 Mn
Sep 30, 2022 57.24 Mn
Jun 30, 2022 53.11 Mn
Mar 31, 2022 43.09 Mn
Dec 31, 2021 38.31 Mn
Sep 30, 2021 35.95 Mn
Jun 30, 2021 36.37 Mn
API Access

Catalyst Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CPRX&period=max&api_key=YOUR_API_KEY